Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia

Erythema nodosum (EN) is a type of panniculitis occurring due to various conditions. It can be associated with certain malignancies or manifest as a side effect of drugs. This article presents a unique case of EN in a patient with chronic myeloid leukemia (CML‐blast phase) following dasatinib and ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassem, Nancy, Alshurafa, Awni, Elsabah, Hesham, El Omri, Halima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665579/
https://www.ncbi.nlm.nih.gov/pubmed/38028081
http://dx.doi.org/10.1002/ccr3.8223
_version_ 1785148882436489216
author Kassem, Nancy
Alshurafa, Awni
Elsabah, Hesham
El Omri, Halima
author_facet Kassem, Nancy
Alshurafa, Awni
Elsabah, Hesham
El Omri, Halima
author_sort Kassem, Nancy
collection PubMed
description Erythema nodosum (EN) is a type of panniculitis occurring due to various conditions. It can be associated with certain malignancies or manifest as a side effect of drugs. This article presents a unique case of EN in a patient with chronic myeloid leukemia (CML‐blast phase) following dasatinib and chemotherapy. Timely recognition and appropriate management are crucial to alleviate symptoms and consider potential drug‐induced etiology.
format Online
Article
Text
id pubmed-10665579
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106655792023-11-22 Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia Kassem, Nancy Alshurafa, Awni Elsabah, Hesham El Omri, Halima Clin Case Rep Case Report Erythema nodosum (EN) is a type of panniculitis occurring due to various conditions. It can be associated with certain malignancies or manifest as a side effect of drugs. This article presents a unique case of EN in a patient with chronic myeloid leukemia (CML‐blast phase) following dasatinib and chemotherapy. Timely recognition and appropriate management are crucial to alleviate symptoms and consider potential drug‐induced etiology. John Wiley and Sons Inc. 2023-11-22 /pmc/articles/PMC10665579/ /pubmed/38028081 http://dx.doi.org/10.1002/ccr3.8223 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kassem, Nancy
Alshurafa, Awni
Elsabah, Hesham
El Omri, Halima
Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia
title Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia
title_full Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia
title_fullStr Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia
title_full_unstemmed Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia
title_short Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia
title_sort erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665579/
https://www.ncbi.nlm.nih.gov/pubmed/38028081
http://dx.doi.org/10.1002/ccr3.8223
work_keys_str_mv AT kassemnancy erythemanodosumfollowingtreatmentwithdasatinibpluschemotherapyinapatientwithmyeloidblastphaseofchronicmyeloidleukemia
AT alshurafaawni erythemanodosumfollowingtreatmentwithdasatinibpluschemotherapyinapatientwithmyeloidblastphaseofchronicmyeloidleukemia
AT elsabahhesham erythemanodosumfollowingtreatmentwithdasatinibpluschemotherapyinapatientwithmyeloidblastphaseofchronicmyeloidleukemia
AT elomrihalima erythemanodosumfollowingtreatmentwithdasatinibpluschemotherapyinapatientwithmyeloidblastphaseofchronicmyeloidleukemia

Ejemplares similares